Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
1059-1067
Cudkowicz, Merit E.
36af909f-1e10-41b2-928d-3c0a3be903ab
van den Berg, Leonard H.
bd6ed390-a56e-48d3-8273-a139bdaca4da
Shefner, Jeremy M.
303d647e-e101-4c55-b34f-7e4f465e7fe6
Mitsumoto, Hiroshi
db647877-26ce-44ec-bbfa-dbdbaa87f69d
Mora, Jesus S.
43567725-99f6-45ba-87cc-41f38b2b1d31
Ludolph, Albert
a330bdef-8d11-4e11-ae90-6d2187a6e25f
Hardiman, Orla
95816121-f024-4ca0-bc95-426d778e5b80
Bozik, Michael E.
6ff9ea02-7793-4a8a-b116-4a7aad1e74b1
Ingersoll, Evan W.
c7e050f9-93aa-46ac-a0bb-1797e03470e3
Archibald, Donald
3b16c87c-e607-4875-9572-2f6fdc221e94
Meyers, Adam L.
83a567a1-9298-4d71-b9c2-26989556f68c
Dong, Yingwen
3e016018-52fe-430d-8dca-704e437fcf2e
Farwell, Wildon R.
92606f9c-ecdd-43ef-90cd-aa3abfc3389e
Kerr, Douglas A.
7fb39771-fac1-4fda-a423-99826d254f1c
Morrison, Karen
f00890f0-2fde-4dbd-a73b-7422e1b0ede8
November 2013
Cudkowicz, Merit E.
36af909f-1e10-41b2-928d-3c0a3be903ab
van den Berg, Leonard H.
bd6ed390-a56e-48d3-8273-a139bdaca4da
Shefner, Jeremy M.
303d647e-e101-4c55-b34f-7e4f465e7fe6
Mitsumoto, Hiroshi
db647877-26ce-44ec-bbfa-dbdbaa87f69d
Mora, Jesus S.
43567725-99f6-45ba-87cc-41f38b2b1d31
Ludolph, Albert
a330bdef-8d11-4e11-ae90-6d2187a6e25f
Hardiman, Orla
95816121-f024-4ca0-bc95-426d778e5b80
Bozik, Michael E.
6ff9ea02-7793-4a8a-b116-4a7aad1e74b1
Ingersoll, Evan W.
c7e050f9-93aa-46ac-a0bb-1797e03470e3
Archibald, Donald
3b16c87c-e607-4875-9572-2f6fdc221e94
Meyers, Adam L.
83a567a1-9298-4d71-b9c2-26989556f68c
Dong, Yingwen
3e016018-52fe-430d-8dca-704e437fcf2e
Farwell, Wildon R.
92606f9c-ecdd-43ef-90cd-aa3abfc3389e
Kerr, Douglas A.
7fb39771-fac1-4fda-a423-99826d254f1c
Morrison, Karen
f00890f0-2fde-4dbd-a73b-7422e1b0ede8